To evaluate PSA levels and kinetic cutoffs to predict positive bone scans for men with non-metastatic castration-resistant prostate cancer (CRPC) from the Shared Equal Access Regional Cancer ...

A bone scan is a nuclear imaging test that can help tell you if you have certain types of bone disease. You may get this kind of scan to see if cancer has spread to your bones or to view how well ...

A key gene that fuels the molecular cascade driving prostate cancer bone metastasis progression may open avenues for targeted therapies. Laura is an assistant editor for The Scientist. She earned her ...

Patients with mCRPC prostate cancer have an elevated risk of fractures due to bone metastases and use of androgen receptor pathway inhibitors (ARPI).

Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by ...

A 66-year-old male patient underwent surgery for prostate cancer 4 years ago. His initial prostate-specific antigen (PSA) ...

For patients with metachronous low burden mCSPC on conventional imaging being recommended for systemic therapy, 51% responded ...

PSMA PET/CT trial will scan up to 1000 men in the UKA new kind of scan that could be key to improving the treatment of high-risk prostate cancer is ...

One test could have prevented terminal prostate cancer, says patient - Research has shown that the use of the PSA test varies ...

Medically reviewed by Doru Paul, MD Stage 4 prostate cancer is the most advanced stage of the disease. It means that cancer ...

Before the scan, you get an injection of fluciclovine ... a long-term effort has identified cells in the bone marrow that originated from prostate cancer, even in the absence of other evidence of ...

About 7 percent of prostate cancer cases are metastatic. This means the cancer has spread from the prostate into other parts of the body. Prostate cancer commonly metastasizes to the bones.